Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History, updating the list of study record revisions.SummaryDifference0.1%

- Check23 days agoChange DetectedThe record history shows that revision v3.4.3 was added and revision v3.4.2 was removed from the version list.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding/operating status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedAdded a government funding notice and updated the history to v3.4.1, while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check65 days agoChange DetectedNew UI elements include a glossary toggle, color-coded green additions and red deletions, and an updated revision label to enhance the history display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check79 days agoChange DetectedThe Record History page now shows Revision: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.